[1] |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424.
doi: 10.3322/caac.v68.6
URL
|
[2] |
Anantharaman D, Marron M, Lagiou P, et al. Population attributable risk of tobacco and alcohol for upper aerodigestive tract cancer[J]. Oral Oncol, 2011, 47(8): 725-731.
doi: 10.1016/j.oraloncology.2011.05.004
pmid: 21684805
|
[3] |
Yagi T, Takeichi M. Cadherin superfamily genes: functions, genomic organization, and neurologic diversity[J]. Genes Dev, 2000, 14(10): 1169-1180.
doi: 10.1101/gad.14.10.1169
URL
|
[4] |
Pishvaian MJ, Feltes CM, Thompson P, et al. Cadherin11 is expressed in invasive breast cancer cell lines[J]. Cancer Res, 1999, 59(4): 947-952.
pmid: 10029089
|
[5] |
Huang CF, Lira C, Chu K, et al. Cadherin11 increases migration and invasion of prostate cancer cells and enhances their interaction with osteoblasts[J]. Cancer Res, 2010, 70(11): 4580-4589.
|
[6] |
Marchong MN, Yurkowski C, Ma C, et al. CDH11 acts as a tumor suppressor in a murine retinoblastoma model by facilitating tumor cell death[J]. PLoS Genet, 2010, 6(4): e1000923.
doi: 10.1371/journal.pgen.1000923
URL
|
[7] |
Li L, Ying J, Li H, et al. The human cadherin 11 is a pro-apoptotic tumor suppressor modulating cell stemness through Wnt/β-catenin signaling and silenced in common carcinomas[J]. Oncogene, 2012, 31(34): 3901-3912.
doi: 10.1038/onc.2011.541
pmid: 22139084
|
[8] |
Chu K, Cheng CJ, Ye XC, et al. Cadherin-11 promotes the metastasis of prostate cancer cells to bone[J]. Mol Cancer Res, 2008, 6(8): 1259-1267.
doi: 10.1158/1541-7786.MCR-08-0077
pmid: 18708358
|
[9] |
Marie PJ, Hay E, Modrowski D, et al. Cadherin-mediated cell-cell adhesion and signaling in the skeleton[J]. Calcif Tissue Int, 2014, 94(1): 46-54.
doi: 10.1007/s00223-013-9733-7
URL
|
[10] |
Yap AS, Gomez GA, Parton RG. Adherens junctions revisualized: organizing cadherins as nanoassemblies[J]. Dev Cell, 2015, 35(1): 12-20.
doi: 10.1016/j.devcel.2015.09.012
pmid: 26460944
|
[11] |
Alimperti S, Andreadis ST. CDH2 and CDH11 act as regulators of stem cell fate decisions[J]. Stem Cell Res, 2015, 14(3): 270-282.
doi: 10.1016/j.scr.2015.02.002
pmid: 25771201
|
[12] |
Bujko M, Kober P, Mikula M, et al. Expression changes of cell-cell adhesion-related genes in colorectal tumors[J]. Oncol Lett, 2015, 9(6): 2463-2470.
pmid: 26137091
|
[13] |
Mueller DW, Bosserhoff AK. MicroRNA miR-196a controls melanoma-associated genes by regulating HOX-C8 expression[J]. Int J Cancer, 2011, 129(5): 1064-1074.
doi: 10.1002/ijc.25768
pmid: 21077158
|
[14] |
Sandgren J, Andersson R, Rada-Iglesias A, et al. Integrative epigenomic and genomic analysis of malignant pheochromocytoma[J]. Exp Mol Med, 2010, 42(7): 484-502.
pmid: 20534969
|
[15] |
Nakajima G, Patino-Garcia A, Bruheim S, et al. CDH11 expression is associated with survival in patients with osteosarcoma[J]. Cancer Genomics Proteomics, 2008, 5(1): 37-42.
|
[16] |
Satriyo PB, Bamodu OA, Chen JH, et al. Cadherin 11 inhibition downregulates β-catenin, deactivates the canonical WNT signalling pathway and suppresses the cancer stem cell-like phenotype of triple negative breast cancer[J]. J Clin Med, 2019, 8(2): E148.
|